Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 1999
Business Overview: The Company manufactures laboratory and technical products. As of August 27, 1999, there were 2,447,046 shares of Common Stock outstanding.
Key Financial Metrics
| Metric ($ in thousands) | Q1 1999 | Q1 1998 |
|---|---|---|
| Net Sales | $20,065 | $19,624 |
| Gross Profit | $4,630 | $4,422 |
| Gross Margin | 23.1% | 22.5% |
| Operating Earnings | $1,361 | $1,299 |
| Net Earnings | $904 | $766 |
| Diluted EPS | $0.37 | $0.31 |
| Working Capital | $10,863 | N/A |
| Cash and Equivalents | $8 | $471 |
| Short-term Borrowings | $2,249 | N/A |
Cash Flow Summary (Three months ended July 31, 1999):
- Net cash used in operating activities: $(672) thousand
- Net cash used in investing activities: $(525) thousand
- Net cash provided by financing activities: $1,197 thousand
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.2% to $20.1 million, driven by higher technical product sales, partially offset by lower laboratory product sales.
- Profitability: Gross profit margin improved to 23.1% from 22.5% due to product mix changes. Operating earnings rose to $1.4 million from $1.3 million.
- Expenses: Operating expenses increased to $3.3 million (16.3% of sales) from $3.1 million (15.9% of sales), primarily due to higher sales commissions.
- Interest Expense: Increased to $39,000 from $12,000 due to higher utilization of the revolving credit facility.
- Unusual Items: Other income of $148,000 was recorded, primarily from a $140,000 litigation settlement regarding supplier overcharges.
- Liquidity: Working capital increased to $10.9 million. Short-term borrowings rose to $2.2 million to support operations.
Outlook, Risks, and Management Commentary
- Liquidity Outlook: Management believes funds from operations and short-term borrowings are sufficient to support ongoing business and capital expenditures through the current fiscal year.
- Year 2000 (Y2K) Compliance: Major business systems were compliant as of April 30, 1999. Remediation is expected to be fully completed by September 30, 1999. Total Y2K expenditures are expected to be less than $100,000.
- Risks: The greatest Y2K exposure is associated with third-party suppliers rather than internal systems. The Company cannot estimate potential damages from supplier failures but is assessing contingency plans.
- Capital Expenditures: $525,000 was spent on production equipment in the quarter, down from $1.1 million in the prior year.
Investor Verification Checklist
- Verify the sustainability of the 23.1% gross margin given the shift in product mix.
- Monitor the level of short-term borrowings ($2.2 million) and its impact on future interest expenses.
- Assess the status of supplier Y2K compliance and the adequacy of contingency plans.
- Review the trend in operating expenses as a percentage of sales (currently 16.3%).
- Confirm the cash burn rate in operating activities ($672k used) and its relation to receivables and inventory growth.